OssDsign AB (publ) publishes Q1 2021 Interim Report

Strong momentum, new strategy, and capital securedThe first quarter in figures  · Net sales amounted to TSEK 5,987 (7,726). · Loss after taxes amounted to TSEK 23,329 (18,312). · Earnings per share was SEK -1.1 (-1.0). · Cash flow from current operations was TSEK -23,334 (-22,366). Important events during the first quarter  · New clinical data from 1,055 cranioplasty procedures with OssDsign Cranial PSI continue to show low complication rates. · OssDsign completes expansion into new corporate headquarters in Uppsala, Sweden. · OssDsign’s Board of Directors